(Q43075090)

13 November 2017

Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis (English)

1 reference

13 November 2017

Tadashi Nakamura

1

1 reference

13 November 2017

Syu-ichi Higashi

2

1 reference

13 November 2017

Kunihiko Tomoda

3

1 reference

13 November 2017

Michishi Tsukano

4

1 reference

13 November 2017

Masahiro Shono

5

1 reference

13 November 2017

5 May 2010

1 reference

13 November 2017

Clinical Rheumatology

1 reference

13 November 2017

29

1 reference

13 November 2017

12

1 reference

13 November 2017

1395-1401

1 reference

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

13 November 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Pathology, diagnosis and pathogenesis of AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Natural history and outcome in systemic AA amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Significance of SAA1.3 allele genotype in Japanese patients with amyloidosis secondary to rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Amyloid P component. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Regulation of serum amyloid A protein expression during the acute-phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Amyloidosis: new strategies for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10067-010-1469-4

Massive hematuria due to bladder amyloidosis in patients with rheumatoid arthritis: three case reports

21 January 2018

1 reference

12 December 2020

A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis

1 reference

12 December 2020

Gustatory sweating due to autonomic neuropathy in a patient with amyloidosis secondary to rheumatoid arthritis

1 reference

12 December 2020

Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis

1 reference

12 December 2020

Combined treatment with cyclophosphamide and prednisolone is effective for secondary amyloidosis with SAA1γ/γ genotype in a patient with rheumatoid arthritis

1 reference

12 December 2020

Therapeutic criteria in rheumatoid arthritis

1 reference

12 December 2020

Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy

1 reference

12 December 2020

Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis

1 reference

12 December 2020

Presentation, survival and prognostic markers in AA amyloidosis

1 reference

12 December 2020

Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.

1 reference

12 December 2020

Mechanism of reduced amyloid-A-degrading activity in serum of patients with secondary amyloidosis

1 reference

12 December 2020

Secondary systemic amyloidosis: response and survival in 64 patients

1 reference

12 December 2020

Quick prediction of creatinine clearance without the necessity of urine collection.

1 reference

12 December 2020

Cardiovascular death in rheumatoid arthritis: a population-based study

1 reference

12 December 2020

Amyloidosis as a cause of death in patients with rheumatoid arthritis

1 reference

12 December 2020

Clinical strategies for amyloid A amyloidosis secondary to rheumatoid arthritis

1 reference

12 December 2020

Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid A amyloidosis complicating juvenile idiopathic arthritis

1 reference

12 December 2020

Why can we no longer find juvenile idiopathic arthritis-associated amyloidosis in childhood or in adolescence in Finland?

1 reference

12 December 2020

10.1007/S10067-010-1469-4

Identifiers

DOI

1 reference

13 November 2017

1 reference